BELSOMRA
Active substance: suvorexant
TABLET, FILM COATED · SUVOREXANT 15 mg/1
United StatesActive
Marketing holder: Merck Sharp & Dohme LLC
Verified 2026-10-09 · openFDA NDC
Analogues in other countries- Source: openFDA NDC
- Countries with the substance registered: 2
Composition
- SUVOREXANT · 15 mg/1
Analogues by country
Products with the same active substance registered in other countries.
| Country | Products |
|---|---|
| RU 1 |
|
Import and control
Control by country
- Russiaprescription only
Source: GRLS (Russian state register) · record 01a120c4-b92a-730d-8de1-8b10d6d5ea01;count=1 · valid from 2026-10-09 · verified 2026-10-09
- United StatescontrolledSchedule: CIV
Source: openFDA NDC · record 01a1208e-1672-75b6-a6f0-783651fd7a2e,01a1208e-16fb-7405-a49a-f5603fe75abe,01a1208f-9a32-74b0-86d1-d5f91df73e70,01a12098-1e4e-70e0-97eb-cbbd27abd171;count=4 · valid from 2026-10-09 · verified 2026-10-09
Registration
- Registration number
- 0006-0325
- Registration status
- Active
- Dispensing
- Prescription only
- Control marker
- CIV
- Route
- ORAL
Sources
- product · openFDA NDC · 0006-0325 · Verified 2026-10-09 · open in source
- registration_status · openFDA NDC · 0006-0325 · Verified 2026-10-09 · open in source
- ingredients.0 · openFDA NDC · 0006-0325 · Verified 2026-10-09 · open in source